Located at Changodar in Ahmedabad, the R&D centre is built over 14,374 sq. mt and has the latest, state-of-the-art technologies installed that will enable Epigral to catalyse identification of specialty chemical molecules for later introduction in India. The company has consciously strived towards creating a key differentiator for itself by graduating from being a chemical manufacturer to developing research-driven products, in-house.

The centre has been developed with an initial investment of Rs. 30 crore and the company will further invest to enhance its capability as its proceeds further.